PedAM
Pediatric Disease Annotations & Medicines
| Disease | hepatitis b |
| Phenotype | C0022658|kidney disease |
| Sentences | 7 |
| PubMedID- 24299322 | Background: the treatment of chronic hepatitis b (chb) in patients with chronic kidney disease (ckd) is based on nucleoside (lamivudine, telbivudine, entecavir) or nucleotide (adefovir, tenofovir) analogues (nas), but it may be complex and the information is scarce. |
| PubMedID- 22285268 | Aim: to evaluate the efficacy and safety of adjuvantation for hepatitis b virus vaccine in patients with chronic kidney disease. |
| PubMedID- 24592546 | The advent of nucleos(t)ide analogues offers the opportunity to change the natural history of hepatitis b in patients with chronic kidney disease. |
| PubMedID- 23783238 | Treatment of hepatitis b in patients with chronic kidney disease. |
| PubMedID- 22930501 | Unexpected distribution of hepatitis b genotypes in patients with kidney disease: comparison with immunocompetent subjects. |
| PubMedID- 22224074 | Immune response to hepatitis b vaccine in patients with chronic kidney disease. |
| PubMedID- 22142584 | Vitamin d deficiency is associated with poor response to active hepatitis b immunisation in patients with chronic kidney disease. |
Page: 1